Mucin function in inflammatory bowel disease: An update

Journal of Clinical Gastroenterology

Volumn 47, Issue 2, 2013, Pages 106-111

  Boltin, Doron ^a   Perets, Tsachi T ^a   Vilkin, Alex ^a   Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ER stress; goblet cell; inflammatory bowel disease; intestinal epithelium; MUC2; mucin; mucosal barrier; unfolded protein response

Indexed keywords

ANTIBODY; BETA CATENIN; FATTY ACID SYNTHASE; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MUCIN; MUCIN 13; MUCIN 17; MUCIN 2; MUCIN 3; MUCIN 5AC; MUCIN 6; MUCIN ANTIBODY; NICOTINE; OLIGOSACCHARIDE; SIALOMUCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

APOPTOSIS; BACTERIAL COLONIZATION; CHRONIC INFLAMMATION; COLITIS; COLON MUCOSA; CROHN DISEASE; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL FACTOR; EXOCYTOSIS; GENE MUTATION; GLYCOSYLATION; HEREDITY; HUMAN; IMMUNE RESPONSE; INTESTINE POLYP; LIPOGENESIS; NEOPLASM; NONHUMAN; PALMITOYLATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECTUM TUMOR; REVIEW; SIALYLATION; SMOKING; SULFATION; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; BACTERIAL TRANSLOCATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MUCINS; MUTATION; PERMEABILITY; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RISK FACTORS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84872947175     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182688e73     Document Type: Review

References (60)

1. Senapati S, Das S, Batra SK. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci. 2010;35:236-245.
2. Theodoropoulos G, Carraway KL. Molecular signaling in the regulation of mucins. J Cell Biochem. 2007;102:1103-1116.
3. Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta. 2006;1765:189-222.
4. Moncada DM, Kammanadiminti SJ, K Chadee. Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol. 2003;19:305-311.
5. McAuley JL, Linden SK, Png CW, et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007;117:2313-2324.
6. Knight PA, Brown JK, Pemberton AD. Innate immune response mechanisms in the intestinal epithelium: potential roles for mast cells and goblet cells in the expulsion of adult Trichinella spiralis. Parasitology. 2008;135:655-670.
7. Hasnain SZ, Wang H, Ghia JE, et al. Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. Gastroenterology. 2010;138:1763-1771.
8. Hasnain SZ, Evans CM, Roy M, et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med. 2011;208:893-900.
9. Goldston AM, Powell RR, Koushik AB, et al. Exposure to host ligands correlates with co-localization of Gal/GalNAc lectin subunits in lipid rafts and PIP2 signaling in Entamoeba histolytica. Eukaryot Cell. 2012;11:743-751.
10. Lidell ME, Moncada DM, Chadee K, et al. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci USA. 2006;103:9298-9303.
11. Podolsky DK, Gerken G, Eyking A, et al. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology. 2009;137:209-220.
12. Ahmad R, Raina D, Trivedi V, et al. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. Nat Cell Biol. 2007;9:1419-1427.
13. Karlsson NG, Olson FJ, Jovall PA, et al. Identification of transient glycosylation alterations of sialylated mucin oligo-saccharides during infection by the rat intestinal parasite Nippostrongylus brasiliensis. Biochem J. 2000;350:805-814.
14. Pullan RD, Thomas GA, Rhodes M, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994;35:353-359.
15. Myerscough N, Warren B, M Gough, et al. Expression of mucin gene in ulcerative colitis. Biochem Soc Trans. 1995;23:536S.
16. Raouf AH, Tsai HH, Parker N, et al. Sulphation of colonic mucin in ulcerative colitis and Crohn's disease. Clin Sci. 1992;83:623-626.
17. Van Klinken BJ, Van der Wal JW, Einerhand AW, et al. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut. 1999;44: 387-393.
18. Larsson JM, Karlsson H, Crespo JG, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcer-ative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 2011;17:2299-2307.
19. Parker N, Tsai HH, Ryder SD, et al. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion. 1995;56:52-56.
20. Buisine MP, Desreumaux P, Debailleul V, et al. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis. 1999;5:24-32.
21. Longman RJ, Poulsom R, Corfield AP, et al. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem. 2006;54:1335-1348.
22. Moehle C, Ackermann N, Langmann T, et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med. 2006;84:1055-1066.
23. An G, Wei B, Xia B, et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med. 2007;204:1417-1429.
24. Kyo K, Muto T, Nagawa H, et al. Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease. J Hum Genet. 2001;46:5-20.
25. Buisine MP, Desreumaux P, Leteurtre E, et al. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut. 2001;49:544-551.
26. Senapati S, Ho SB, Sharma P, et al. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neo-plastic diseases of the colon. J Clin Pathol. 2010;63:702-707.
27. Takaishi H, Ohara S, Hotta K, et al. Circulating autoanti-bodies against purified colonic mucin in ulcerative colitis. J Gastroenterol. 2000;35:20-27.
28. Hinoda Y, Nakagawa N, Nakamura H, et al. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol Lett. 1993;35: 163-168.
29. Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105:2420-2428.
30. Prindiville M, Cantrell M, Gershwin ME. Characterization and heterogeneity of monoclonal antibodies directed to intestinal mucin derived from Crohn's disease small bowel. Hybridoma. 1991;10:269-280.
31. Kaneko Y, Nakamura T, Hayama M, et al. Altered expression of CDX-2, PDX-1 and mucin core proteins in "Ulcer-associated cell lineage (UACL)" in Crohn's disease. J Mol Histol. 2008;39:161-168.
32. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
33. Satsangi J, Parkes M, Louis E. Two-stage genome-wide search in inflammatory bowel disease: evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996;14: 199-202.
34. Sabbah A, Chang TH, Harnack R, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009;10:1073-1080.
35. Hoskins LC. Mucin glycoprotein degradation by mucin oligosaccharide- degrading strains of human faecal bacteria. Characterisation of saccharide cleavage products and their potential role in nutritional support of larger faecal bacterial populations. Microb Ecol Health Dis. 1992;5:193-207.
36. Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA. 2008;105: 15064-15069.
37. Johansson ME, Gustafsson JK, Sjoberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One. 2010;18:e12238.
38. Croix JA, Carbonero F, Nava GM, et al. On the relationship between sialomucin and sulfomucin expression and hydro-genotrophic microbes in the human colonic mucosa. PLoS One. 2011;6:e24447.
39. Fu J, Wei B, Wen T, et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;121:1657-1666.
40. Forgue-Lafitte ME, Fabiani B, Levy PP, et al. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer. Int J Cancer. 2007;121:1543-1549.
41. McGovern DP, Gardet A, Torkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010;42:332-337.
42. Kyo K, Parkes M, Takei Y, et al. Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet. 1999;8:307-311.
43. Swallow DM, Vinall LE, Gum JR, et al. Ulcerative colitis is not associated with differences in MUC2 mucin allele length. J Med Genet. 1999;36:859-860.
44. Tsai HH, Dwarakanath AD, Hart CA, et al. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut. 1995;36:570-576.
45. Nishida A, Lau CW, Zhang M, et al. The membrane-bound mucin muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012;142:865-874.
46. Bhatti MA, Hodgson HJF. Nicotine down-regulates IL-8 production and tissue expression in inflammatory bowel disease. Gastroenterology. 1997;112:A934.
47. Louvet B, Buisine MP, Desreumaux P, et al. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis. Inflamm Bowel Dis. 1999;5:174-181.
48. Agawa S, Muto T, Morioka Y. Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia. Dis Colon Rectum. 1988;31:387-389.
49. Issaacson P, Attwood PRA. Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonic carcinoma. J Clin Pathol. 1979;32:214-218.
50. Tatsumi N, Kushima R, Vieth M, et al. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. Virchows Arch. 2006;448:756-762.
51. - mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol. 2007;179:735-739.
52. Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell. 2005;7:167-178.
53. Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295: 1726-1729.
54. Yang K, Popova NV, Yang WC, et al. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res. 2008;68:7313-7322.
55. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134:743-756.
56. Zhao F, Edwards R, Dizon D, et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2~/~ mice. Dev Biol. 2010;338270-279.
57. Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5:e54.
58. Wei X, Yang Z, Rey FE, et al. Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe. 2012;11:140-152.
59. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259-263.
60. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39:207-211.